Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Patient -Blind Controlled Phase III Study to Compare the Efficacy and Safety of Intravenous Ferric Carboxymaltose (Ferinject®) With Placebo in Patients With Acute Isovolemic Anemia After Gastrectomy

NCT01725789 is registered in ClinicalTrials.gov with National Cancer Center, Korea as lead sponsor.

NCT NCT01725789
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01725789 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Patient -Blind Controlled Phase III Study to Compare the Efficacy and Safety of Intravenous Ferric Carboxymaltose (Ferinject®) With Placebo in Patients With Acute Isovolemic Anemia After Gastrectomy
Lead sponsor
National Cancer Center, Korea
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2012
Completion date
April 30, 2016
Enrollment
454 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

anemia